Osteoporosis Outlook to 2026 in Europe: Analysis on Epidemiology, Patient Flow, Prevalence and Diagnosed & Treated Patients - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--Jul 13, 2018--The “Europe Osteoporosis Epidemiology and Patient Flow Analysis - 2018” report has been added to ResearchAndMarkets.com’s offering.
The research provides insights into Osteoporosis epidemiology, Osteoporosis diagnosed patients, and Osteoporosis treatment rate for EU5 countries. The research measures key indicators including prevalence of Osteoporosis derived from epidemiological analysis, patients diagnosed with Osteoporosis, and patients treated with a drug therapy.
The research study helps executives estimate Osteoporosis market potential, assess unmet need, develop drug forecasting models, and build population-based health management frameworks. The information presented in this study is used to evaluate market opportunities, effectively identify target patient population, and align marketing decisions.
The research provides estimates and forecasts of Osteoporosis prevalence, Osteoporosis diagnosis rate, and Osteoporosis treatment rate for the period 2017-2026. The information is presented by EU5 countries including Germany, France, Spain, Italy, and UK.
Key Topics Covered
1. Osteoporosis: Disease Definition
2. Osteoporosis Patient Flow in Europe 2A. Osteoporosis Prevalence in Europe 2B. Osteoporosis Diagnosed Patients in Europe 2C. Osteoporosis Treated Patients in Europe
3. Osteoporosis Patient Flow in Germany 3A. Osteoporosis Prevalence in Germany 3B. Osteoporosis Diagnosed Patients in Germany 3C. Osteoporosis Treated Patients in Germany
4. Osteoporosis Patient Flow in France 4A. Osteoporosis Prevalence in France 4B. Osteoporosis Diagnosed Patients in France 4C. Osteoporosis Treated Patients in France
5. Osteoporosis Patient Flow in Spain 5A. Osteoporosis Prevalence in Spain 5B. Osteoporosis Diagnosed Patients in Spain 5C. Osteoporosis Treated Patients in Spain
6. Osteoporosis Patient Flow in Italy 6A. Osteoporosis Prevalence in Italy 6B. Osteoporosis Diagnosed Patients in Italy 6C. Osteoporosis Treated Patients in Italy
7. Osteoporosis Patient Flow in UK 7A. Osteoporosis Prevalence in UK 7B. Osteoporosis Diagnosed Patients in UK 7C. Osteoporosis Treated Patients in UK
8. Research Methodology
For more information about this report visit https://www.researchandmarkets.com/research/rdtz6l/osteoporosis?w=4
Did you know that we also offer Custom Research? Visit our Custom Research page to learn more and schedule a meeting with our Custom Research Manager.
View source version on businesswire.com:https://www.businesswire.com/news/home/20180713005226/en/
Laura Wood, Senior Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics:Endocrine and Metabolic Disorders Drugs,Musculoskeletal Disorders Drugs
INDUSTRY KEYWORD: HEALTH PHARMACEUTICAL RESEARCH SCIENCE
SOURCE: Research and Markets
Copyright Business Wire 2018.
PUB: 07/13/2018 09:24 AM/DISC: 07/13/2018 09:24 AM